BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9657093)

  • 1. Optimal timing of liver transplantation for primary biliary cirrhosis.
    Kim WR; Wiesner RH; Therneau TM; Poterucha JJ; Porayko MK; Evans RW; Klintmalm GB; Crippin JS; Krom RA; Dickson ER
    Hepatology; 1998 Jul; 28(1):33-8. PubMed ID: 9657093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.
    van Dam GM; Gips CH; Reisman Y; Maas KW; Purmer IM; Huizenga JR; Verbaan BW
    Hepatogastroenterology; 1999; 46(25):108-15. PubMed ID: 10228773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation.
    van Dam GM; Verbaan BW; Therneau TM; Dickson ER; Malinchoc M; Murtaugh PA; Huizenga JR; Gips CH
    Hepatogastroenterology; 1997; 44(15):732-43. PubMed ID: 9222682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of the role of the Mayo Risk Score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis.
    Gilroy RK; Lynch SV; Strong RW; Kerlin P; Balderson GA; Stuart KA; Crawford DH
    Liver Transpl; 2000 Nov; 6(6):749-52. PubMed ID: 11084062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.
    Talwalkar JA; Seaberg E; Kim WR; Wiesner RH
    Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.
    Reisman Y; van Dam GM; Gips CH; Lavelle SM; Euricterus PM
    Hepatogastroenterology; 1997; 44(16):982-9. PubMed ID: 9261586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates.
    Kim WR; Wiesner RH; Poterucha JJ; Therneau TM; Benson JT; Krom RA; Dickson ER
    Liver Transpl; 2000 Jul; 6(4):489-94. PubMed ID: 10915173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.
    Wiesner RH; Porayko MK; Dickson ER; Gores GJ; LaRusso NF; Hay JE; Wahlstrom HE; Krom RA
    Hepatology; 1992 Nov; 16(5):1290-9. PubMed ID: 1427667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
    Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative predictors of resource utilization in liver transplantation.
    Kim WR; Therneau TM; Dickson ER; Evans RW
    Clin Transpl; 1995; ():315-22. PubMed ID: 8794277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center.
    Liermann Garcia RF; Evangelista Garcia C; McMaster P; Neuberger J
    Hepatology; 2001 Jan; 33(1):22-7. PubMed ID: 11124816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.
    Wiesner RH
    Mayo Clin Proc; 1998 Jun; 73(6):575-88. PubMed ID: 9621867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis: relation between hepatic function and pulmonary function in patients who never smoked.
    Krowka MJ; Grambsch PM; Edell ES; Cortese DA; Dickson ER
    Hepatology; 1991 Jun; 13(6):1095-100. PubMed ID: 2050328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival algorithms and outcome analysis in primary biliary cirrhosis.
    Pasha TM; Dickson ER
    Semin Liver Dis; 1997 May; 17(2):147-58. PubMed ID: 9170202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal.
    Campsen J; Zimmerman M; Trotter J; Wachs M; Bak T; Steinberg T; Kaplan M; Kam I
    Transplant Proc; 2009 Jun; 41(5):1707-12. PubMed ID: 19545712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis.
    Garcia CE; Garcia RF; Gunson B; Christensen E; Neuberger J; McMaster P; Mirza DF
    Exp Clin Transplant; 2004 Jun; 2(1):183-8. PubMed ID: 15859926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.
    Poupon RE; Bonnand AM; Chrétien Y; Poupon R
    Hepatology; 1999 Jun; 29(6):1668-71. PubMed ID: 10347106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.